Key result
Elevated morning home blood pressure in obese patients with type 2 diabetes mellitus significantly predicted a higher risk of death (HR 3.4) compared to normotension over a 10-year follow-up.
Why the study?
Does morning home blood pressure measurement provide stronger predictive power for death and vascular complications than clinic blood pressure in non-obese and obese patients with type 2 diabetes mellitus?
Cohort (n=400)
No
Does morning home blood pressure measurement provide stronger predictive power for death and vascular complications than clinic blood pressure in non-obese and obese patients with type 2 diabetes mellitus?
Hazard Ratio: 3.4 (95% CI 1.8–9.9)
Absolute Event Rate: 37.5% vs 13.2%
p-value: p=0.001
Morning home blood pressure is a significantly stronger predictor of mortality and vascular complications than clinic blood pressure in obese patients with type 2 diabetes.
It was demonstrated that home blood pressure (HBP) has a stronger predictive power for death, micro- and macrovascular complications than clinic blood pressure (CBP) in patients with type 2 diabetes mellitus (T2DM). This study investigated which of these measurements offers predicatively stronger power for outcomes over 10 years in non-obese and obese patients with T2DM.
No takes yet. Share an insight, caveat, or question.
Kyuzi Kamoi (2015) conducted a cohort in Type 2 Diabetes Mellitus (n=400). Elevated morning home blood pressure (Hypertension) vs. Normotension based on morning home blood pressure was evaluated on Death from any cause (HR 3.4, 95% CI 1.8-9.9, p=0.001). Elevated morning home blood pressure in obese patients with type 2 diabetes mellitus significantly predicted a higher risk of death (HR 3.4) compared to normotension over a 10-year follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: